PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatment of Advanced Non-Small Cell Lung Cancer

PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatme...

November 29, 2021

SpringWorks Completes an Enrollment of Mirdametinib in P-IIb ReNeu Trial for the Treatment of NF1-Associated Plexiform Neurofibromas

SpringWorks Completes an Enrollment of Mirdametinib in P-IIb ReNeu Trial for the Treatment of NF1-Associated Plexiform Neurofibrom...

November 29, 2021

Turnstone Biologics Entered into a Multi-Year Research Collaboration with Moffitt Cancer Center to Advance TIL Immunotherapies for Solid Tumor

Turnstone Biologics Entered into a Multi-Year Research Collaboration with Moffitt Cancer Center to Advance TIL Immunotherapies for...

November 29, 2021

Qiagen and DiaSorin’s QuantiFERON-TB Gold Plus Assay Receives the US FDA’s Approval for the Treatment of Latent Tuberculosis Infection

Qiagen and DiaSorin’s QuantiFERON-TB Gold Plus Assay Receives the US FDA’s Approval for the Treatment of Latent Tuberculosis Infec...

November 29, 2021

The US FDA Placed a Clinical Hold on the Ocugen’s IND Application for Covaxin (BBV152) to Treat COVID-19

The US FDA Placed a Clinical Hold on the Ocugen’s IND Application for Covaxin (BBV152) to Treat COVID-19

November 29, 2021

Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19

Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19

November 29, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us